Search alternatives:
aromatic decrease » dramatic decrease (Expand Search)
small decrease » small increased (Expand Search)
aromatic decrease » dramatic decrease (Expand Search)
small decrease » small increased (Expand Search)
-
481
Post-effect of GO and GO-GA NPs on progeny production of <i>Callosobruchus maculatus.</i>
Published 2025Subjects: -
482
-
483
-
484
PT<sub>50</sub> values of GO and GO-GA NPs against <i>Callosobruchus maculatus.</i>
Published 2025Subjects: -
485
-
486
-
487
-
488
Microarray analysis from GEO database showed TNFAIP9 was enhanced in CKD patients and mice.
Published 2025Subjects: -
489
Overexpression of TNFAIP9 alleviated the renal fibrosis caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
490
Overexpression of TNFAIP9 inhibits the weight loss caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
491
Overexpression of TNFAIP9 inhibited the TNF-α-induced inflammation in HK-2 cells.
Published 2025Subjects: -
492
-
493
Overexpression of TNFAIP9 remitted the renal inflammation caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
494
-
495
Overexpression of TNFAIP9 inhibited the TGF-β-induced fibrosis in HK-2 cells.
Published 2025Subjects: -
496
Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
497
Table 3_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx
Published 2025“…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
-
498
Table 7_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx
Published 2025“…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
-
499
Image 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg
Published 2025“…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
-
500
Table 8_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx
Published 2025“…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”